These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15749424)

  • 21. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
    Cianfoni A; Niku S; Imbesi SG
    AJNR Am J Neuroradiol; 2007 Feb; 28(2):272-7. PubMed ID: 17296993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
    Pozdniakov AV; Tiutin LA; Bisaga GN; Odinak MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(4):36-9. PubMed ID: 11490432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
    Malhotra HS; Jain KK; Agarwal A; Singh MK; Yadav SK; Husain M; Krishnani N; Gupta RK
    Mult Scler; 2009 Feb; 15(2):193-203. PubMed ID: 19181773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography.
    Utriainen M; Metsähonkala L; Salmi TT; Utriainen T; Kalimo H; Pihko H; Mäkipernaa A; Harila-Saari A; Jyrkkiö S; Laine J; Någren K; Minn H
    Cancer; 2002 Sep; 95(6):1376-86. PubMed ID: 12216107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal pole proton preoperative magnetic resonance spectroscopy in patients undergoing surgery for mesial temporal sclerosis.
    Fountas KN; Tsougos I; Gotsis ED; Giannakodimos S; Smith JR; Kapsalaki EZ
    Neurosurg Focus; 2012 Mar; 32(3):E3. PubMed ID: 22380857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid PET in pseudotumoral multiple sclerosis.
    Matías-Guiu JA; Cabrera-Martín MN; Cortés-Martínez A; Pytel V; Moreno-Ramos T; Oreja-Guevara C; Carreras JL; Matías-Guiu J
    Mult Scler Relat Disord; 2017 Jul; 15():15-17. PubMed ID: 28641766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis.
    Tartaglia MC; Narayanan S; De Stefano N; Arnaoutelis R; Antel SB; Francis SJ; Santos AC; Lapierre Y; Arnold DL
    J Neurol; 2002 Oct; 249(10):1382-90. PubMed ID: 12382153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
    AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral metabolism, magnetic resonance spectroscopy and cognitive dysfunction in early multiple sclerosis: an exploratory study.
    Blinkenberg M; Mathiesen HK; Tscherning T; Jønsson A; Svarer C; Holm S; Sellebjerg F; Paulson OB; Hanson LG; Sorensen PS
    Neurol Res; 2012 Jan; 34(1):52-8. PubMed ID: 22196862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis.
    Schiepers C; Van Hecke P; Vandenberghe R; Van Oostende S; Dupont P; Demaerel P; Bormans G; Carton H
    Mult Scler; 1997 Feb; 3(1):8-17. PubMed ID: 9160342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion.
    Borgwardt L; Højgaard L; Carstensen H; Laursen H; Nowak M; Thomsen C; Schmiegelow K
    J Clin Oncol; 2005 May; 23(13):3030-7. PubMed ID: 15860860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy.
    Knowlton RC; Laxer KD; Ende G; Hawkins RA; Wong ST; Matson GB; Rowley HA; Fein G; Weiner MW
    Ann Neurol; 1997 Dec; 42(6):829-37. PubMed ID: 9403474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
    Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
    J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
    Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
    Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Brain metabolic disorders after chemotherapy in the study by magnetic resonance spectroscopy].
    Ciszkowska-Łysoń B; Królicki L; Teska A; Janowicz-Zebrowska A; Krzakowski M; Tacikowska M
    Neurol Neurochir Pol; 2003; 37(4):783-98. PubMed ID: 14746239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
    Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
    J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basal ganglia germinoma: diagnostic value of MR spectroscopy and (11)C-methionine positron emission tomography.
    Fujii Y; Saito Y; Ogawa T; Fujii S; Kamitani H; Kondo S; Horie Y; Togawa M; Senda M; Maegaki Y; Ohno K
    J Neurol Sci; 2008 Jul; 270(1-2):189-93. PubMed ID: 18371980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases.
    Brugarolas P; Bhuiyan M; Kucharski A; Freifelder R
    J Vis Exp; 2017 May; (123):. PubMed ID: 28605366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.